{"id":"W2149134506","doi":"10.1158/1078-0432.ccr-03-0783","title":"Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Drug development; Clinical trial; Surrogate endpoint; Cancer; Cancer drugs; Clinical endpoint; Intensive care medicine; Drug; Clinical Oncology; Oncology; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02868674,0.000367633,0.002907651,0.0001380589,0.0002430956,0.00008663478,0.0003516237,0.0004403559,0.0002042788],"category_scores_gemma":[0.04159534,0.0002067418,0.0005052193,0.0003150896,0.001548979,0.00004815436,0.0002922751,0.0006414708,0.00000326343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004976079,"about_ca_system_score_gemma":0.002511699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002597985,"about_ca_topic_score_gemma":0.0005428621,"domain_scores_codex":[0.9893901,0.005722747,0.00289499,0.0008475041,0.0006749629,0.0004696541],"domain_scores_gemma":[0.8666936,0.131423,0.0008120697,0.0004661012,0.000409193,0.0001960078],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005542019,0.0002119491,0.00001699708,0.01290701,0.0008712693,0.000001209707,0.0001069303,4.222956e-8,8.337103e-8,0.01255917,0.0003934104,0.9723777],"study_design_scores_gemma":[0.007666476,0.0004735008,0.00005615069,0.02099758,0.00167343,0.000002109537,0.0000430134,0.00001615641,0.00002847493,0.4279309,0.5407608,0.0003514052],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002196375,0.9898657,0.001210071,0.0007402093,0.0005170894,0.007005142,0.000356927,0.00001905769,0.00006620567],"genre_scores_gemma":[0.00001307928,0.8945823,0.100381,0.00001323906,0.0004045845,0.003923396,0.00001482748,0.00005845905,0.0006090217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9720263,"threshold_uncertainty_score":0.9942309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.8866212378948998,"score_gpt":0.7355782408196071,"score_spread":0.1510429970752927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}